Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suhuang Zhike Granules for post‑infectious cough in children
CTR20233001Phase 2Completed
- Sponsor
- Beijing Dongfang Yunjia Technology Development
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Suhuang Zhike Granules in postinfectious cough, cough variant asthma (CVA), sponsored by Beijing Dongfang Yunjia Technology Development. Started Sep 2023; status: completed.
02
Drugs
Suhuang Zhike Granules
03
Conditions
postinfectious coughcough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20233001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233001.